Loading...
10 dernières publications
-
Antonio Farina, Macarena Villagrán-García, Anthony Fourier, Anne-Laurie Pinto, Fatima Chorfa, et al.. Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort study. The Lancet Regional Health - Europe, 2024, 44, pp.101011. ⟨10.1016/j.lanepe.2024.101011⟩. ⟨hal-04796087⟩
-
Sandrine Blondel, Nathalie Strazielle, Amel Amara, Rainui Guy, Christine Bain, et al.. Vascular network expansion, integrity of blood–brain interfaces, and cerebrospinal fluid cytokine concentration during postnatal development in the normal and jaundiced rat. Fluids and Barriers of the CNS, 2022, 19 (1), pp.47. ⟨10.1186/s12987-022-00332-0⟩. ⟨hal-04804493⟩
-
Amin Mottahedin, Sandrine Blondel, Joakim Ek, Anna-Lena Leverin, Pernilla Svedin, et al.. N-acetylcysteine inhibits bacterial lipopeptide-mediated neutrophil transmigration through the choroid plexus in the developing brain. Acta Neuropathologica Communications, 2020, 8 (1), pp.4. ⟨10.1186/s40478-019-0877-1⟩. ⟨hal-04804466⟩
-
-
-
-
Philippe Nicolas, Anne Ruiz, Alvaro Cobo-Calvo, Guillaume Fiard, Pascale Giraudon, et al.. The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab. Frontiers in Immunology, 2019, 10, pp.2686. ⟨10.3389/fimmu.2019.02686⟩. ⟨hal-04785226⟩
-
-
-
Patrick Waters, Markus Reindl, Albert Saiz, Kathrin Schanda, Friederike Tuller, et al.. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. Journal of Neurology, Neurosurgery and Psychiatry, 2016, 87 (9), pp.1005-1015. ⟨10.1136/jnnp-2015-312601⟩. ⟨hal-04783550⟩
Documents en texte intégral
30
Notices
25
Publications ouvertes
69 %
Mots clés
Connexins
Relapses
Post-partum
Neuromyelitis optica spectrum disorder T follicular helper cells T follicular regulatory cells B cells rituximab
Central nervous system
Rituximab
Blood-brain barrier
ERRα
CP Neuroscience
MOGAD
Neurological immune-related adverse events
Jaundice
Anti-GFAP encephalomyelitis
Prognosis
Microglia
Circadian clock
Clinically isolated syndrome CIS
Neuromyelitis optica spectrum disorder
Adult neurogenesis
Ependymal cell
Astrocyte
Gunn
Neural antibodies
Endocannabinoid system
Hippocampus
Disease-modifying treatments
Cancer
Area postrema syndrome
CP Molecular biology
Meninges
Blood-brain barriers
Neuroinflammation
GABA
Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation
Toll-like receptor
Aquaporin-4-IgG AQP4-IgG
Myelitis
Blood brain barrier
MOG-IgG associated disorders MOGAD
Bone
MRI
Autoimmune encephalitis
Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone
Neuromyelitis optica
Myelin oligodendrocyte glycoprotein
LAT1
Children
Cerebrospinal fluid
Cannabinoid receptor type 2
Autoimmune diseases
Glia
Immune checkpoint inhibitors
Biomarkers
B cells
Bright
MOG antibodies
Claudin
GSK-3β
Aquaporin-4 antibodies
NMOSD
COVID-19
MOG
Influx constant
Database
Microenvironment
Aquaporin-4 antibody
CRMP5
CD14
Drosophila
Estradiol
Cytokines
Optic neuritis
Biobank
Pregnancy
Cilia
Embryo
Treatment response
Demyelination
Multiple sclerosis MS
Adverse events
Neuraxial analgesia
Glutamate
Blood–brain barrier
Registry
Multiple sclerosis
Neurite outgrowth
Immunosuppressant
Autoantibodies
Blood–CSF barrier
Breastfeeding
Lateral diffusion
Innate immune system
Aquaporin-4
Amino acid
Longitudinally extensive transverse myelitis
Choroid plexus
Cancer immunotherapy
Collapsing response mediator protein
Animal model
Encephalitis
Collaborations